---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-090867"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2024-08-19T23:59:59+00:00"
generated_at: "2026-05-31T08:37:17.594645+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics prices $1.85B in senior notes to fund LifeLabs acquisition

## Summary
- Issued $400M at 4.600% due 2027, $600M at 4.625% due 2029, $850M at 5.000% due 2034.
- Net proceeds to fund LifeLabs purchase price and related costs, plus general corporate purposes.
- 2027 and 2029 notes subject to special mandatory redemption at 101% if LifeLabs deal not completed.
- 2034 notes will remain outstanding even if LifeLabs acquisition is not consummated.
- By-laws amended to provide officer exculpation as permitted by Delaware law.

## SEC filing metadata
- accession: 0001104659-24-090867
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2024-08-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000110465924090867/0001104659-24-090867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000110465924090867/tm2421254d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-090867
- JSON: https://secwatch.observer/filing/0001104659-24-090867.json
- Plain text: https://secwatch.observer/filing/0001104659-24-090867.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.